AstraZeneca (AZN) Broadens AZ&Me Prescription Savings Programs Eligibility
Get Alerts AZN Hot Sheet
Join SI Premium – FREE
AstraZeneca (NYSE: AZN) reports it broadened the income eligibility for its AZ&Me Prescription Savings programs to enable more people to qualify for free medicines.
The new annual household income eligibility levels are $35,000 for individuals, $48,000 for couples, $60,000 for a family of three and $70,000 for a family of four.
Those with an annual household income that falls within the new income eligibility guidelines may receive AstraZeneca medicines for free if they meet all program criteria.
Previously, AstraZeneca provided prescription savings benefits to qualified patients with a total yearly income of $30,000 for individuals, $40,000 for couples, $50,000 for a family of three and $60,000 for a family of four.
The new annual household income eligibility levels are $35,000 for individuals, $48,000 for couples, $60,000 for a family of three and $70,000 for a family of four.
Those with an annual household income that falls within the new income eligibility guidelines may receive AstraZeneca medicines for free if they meet all program criteria.
Previously, AstraZeneca provided prescription savings benefits to qualified patients with a total yearly income of $30,000 for individuals, $40,000 for couples, $50,000 for a family of three and $60,000 for a family of four.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated statistically significant and clinically meaningful improvement in PFS as 1st-line treatment of patients with HER2-mutant advanced non-small ce
- VirTra wins $1.5M Army contract for firearms training in Tajikistan
- Suja Life refinances credit agreement, cuts borrowing spread
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share